Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have recently been in hospital.
- People who have had their heart pumping strength (ejection fraction) measured and whose heart failure stage (NYHA Class) is known.
- People with either a previously diagnosed or newly identified heart failure condition.
- People, or their carer, who can speak and understand English or Irish.
- People who are willing to take part in the study.
- People who live within the area served by the Saolta hospital group in Ireland.
Who may not be able to join:
- People who do not wish to take part in the study.
- People receiving palliative care or who have a life expectancy of less than one year.
- People being discharged from hospital to a skilled nursing facility or nursing home.
- People who have a planned procedure on the mitral or aortic heart valve during their hospital stay or shortly after discharge.
- People who are planned to start kidney dialysis (haemodialysis).
- People who are already taking part in another clinical trial.
- People who, in the opinion of the study doctor, may not be able to fully participate — for example due to a history of not taking medications or attending follow-up appointments, a language barrier, or significant memory or thinking difficulties without the support of a family member or carer.
- People whose heart is not pumping as strongly as it should, but who have no symptoms from it (NYHA Class I), particularly when this is related to a recent heart attack.
- Note: Not being confident with technology does not prevent someone from being considered for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Derek O'Keeffe, MD, PhD, Galway University Hospitals/University of Galway
Phone: +353 861735800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Reduction in re-admission rates
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.